In a pilot study at Imperial College London, stem cells taken from the bone marrow of five people who had recently had a stroke, were then infuse directly into damaged sections of the brain. Four out of the five patients suffered particularly severe strokes resulting in the loss of speech and paralysis down one side.
The patients were then monitored for six months. Three out of the four patients who suffered a severe stroke were able to walk and look after themselves at the end of the six month period. All five, with some help, were mobile and could take part in everyday tasks.
Although the results are promising a much larger trial needs to be performed
For more information please click here.
BSc (Hons) Microbiology
Biovault Family CEO, Kate Sneddon, joined Biovault in July 2009 and became Chief Executive Officer in 2016. As health industry professional her experience includes working as a microbiologist and leader at GSK for over 10 years. Her expertise in cord blood banking has been recognised in her awards, features in Parliamentary Review and Parents Guide to Cord Blood, as well as contributions to research with UCL and others.